The Diagnostic Yield of Whole Genome Sequencing for Patients with Epilepsy

CNS Poster (2024)

PMID

Publication AuthorsArpita Neogi MS, CGC, Robert Rigobello MS, CGC, Jason Chibuk MS, CGC, Carli Andres MS, CGC, Linyan Meng PhD, FACMG, Liesbeth Vossaert PhD, FACMG, Christine Eng MD, Fan Xia PhD, FACMG

BACKGROUND

  • Whole Genome Sequencing (WGS) is a comprehensive test that investigates a large number of genes and multiple variant types.
  • WGS is increasingly being adopted as a first-tier diagnostic tool for various neurodevelopmental disorders per guidelines from American College of Medical Genetics and Genomics (ACMG).
  • However, there is limited information on the utility of WGS for epilepsy disorders.
  • In this study, we reviewed the diagnostic yield of WGS for patients presenting with epilepsy.
image_print